Necklace fibers as histopathological marker in a patient with severe form of X-linked myotubular myopathy

Carregando...
Imagem de Miniatura
Citações na Scopus
16
Tipo de produção
article
Data de publicação
2012
Editora
PERGAMON-ELSEVIER SCIENCE LTD
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
GURGEL-GIANNETTI, Juliana
CONCENTINO, Eralda Luiza de Castro
PESQUERO, Joao Bosco
VAINZOF, Mariz
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
NEUROMUSCULAR DISORDERS, v.22, n.6, p.541-545, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
X-linked myotubular myopathy due to mutations in the MTM1 gene is classically characterized by a severe neonatal phenotype and a typical muscle biopsy presenting globular and centrally located nuclei in muscle myofibers. Recently, four patients with mild late-onset form have been described, a male with a hemizygous mutation and three females with heterozygous mutations in the MTM1 gene. The muscle biopsies were performed at 13-35 years of age and a new histological marker, the necklace fibers, was described. Here, we report two siblings with the pathogenic c.664 C > T mutation in the MTM1 gene, presenting a severe muscle weakness and respiratory impairment requiring ventilatory support since the first months of life until death, at the age of 36 months and 5 months. In the older brother the muscle biopsy, performed at the age of 30 months, showed almost 100% of necklace fibers, which were not present in the younger one submitted to muscle biopsy at 5 months of age. Our findings confirm the necklace fibers can be a histopathological finding of MTM1 myopathies, even in the severe neonatal form, and suggest that the necklace fibers appear or increase in number over time.
Palavras-chave
X-linked myotubular myopathy, Necklace fibers, MTM1 gene, Severe neonatal phenotype
Referências
  1. Bevilacqua JA, 2009, ACTA NEUROPATHOL, V117, P283, DOI 10.1007/s00401-008-0472-1
  2. Biancalana V, 2003, HUM GENET, V112, P135, DOI 10.1007/s00439-002-0869-1
  3. Gurgel-Giannetti J, 2003, J CHILD NEUROL, V18, P235
  4. Jungbluth H, 2008, ORPHANET J RARE DIS, V3, P1
  5. Jungbluth H, 2007, NEUROMUSCULAR DISORD, V17, P338, DOI 10.1016/j.nmd.2007.01.016
  6. Laporte J, 1997, HUM MOL GENET, V6, P1505, DOI 10.1093/hmg/6.9.1505
  7. Laporte J, 2000, HUM MUTAT, V15, P393, DOI 10.1002/(SICI)1098-1004(200005)15:5<393::AID-HUMU1>3.0.CO;2-R
  8. Liewluck T, 2010, NEUROMUSCULAR DISORD, V20, P801, DOI 10.1016/j.nmd.2010.07.273
  9. McEntagart M, 2002, NEUROMUSCULAR DISORD, V12, P939, DOI 10.1016/S0960-8966(02)00153-0
  10. Pierson CR, 2007, NEUROMUSCULAR DISORD, V17, P562, DOI 10.1016/j.nmd.2007.03.010
  11. Romero NB, 2011, NEUROMUSCULAR DISORD, V21, P148, DOI 10.1016/j.nmd.2010.11.009
  12. Romero NB, 2010, NEUROMUSCULAR DISORD, V20, P223, DOI 10.1016/j.nmd.2010.01.014
  13. Tsai TC, 2005, NEUROMUSCULAR DISORD, V15, P245, DOI 10.1016/j.nmd.2004.12.005